Trial Profile
Topiramate Augmentation to a Selective Serotonin Re-Uptake Inhibitor (SSRI) in Treatment-Resistant Generalized Social Phobia: A Double-Blind Placebo-Controlled Trial.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 31 Aug 2020 Status changed from recruiting to discontinued.
- 09 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019.
- 09 Apr 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2018.